^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PM1022

    i
    Other names: PM1022
    Associations
    News
    Trials
    Company:
    Adimab, Biotheus
    Drug class:
    PD-L1 inhibitor, TIGIT inhibitor
    Related drugs:
    Associations
    News
    Trials